Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Study.

NCT07560423 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier de Martigues
Phase
Observational
Started
2025-07-10
Last updated
2026-05-01

Condition(s) studied

Patient SatisfactionCancerQuality of Health Care

Investigational drug(s) / intervention(s)

Multidisciplinary Complex Assessment

Multidisciplinary Complex Assessment: Routine multidisciplinary assessment conducted in a Day Hospital setting involving consultations with healthcare professionals (pharmacist, dietitian, psychologist, social worker, and supportive care providers) as part of standard oncology care.

Study summary

This study aims to evaluate patient satisfaction following a multidisciplinary "complex assessment" conducted in a Day Hospital setting at the Centre Hospitalier de Martigues. This assessment is part of routine care for patients diagnosed with cancer and scheduled to receive injectable anticancer treatment.

During this assessment, patients meet several healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The objective is to identify patient-specific needs and improve coordination of care at an early stage of the treatment pathway.

This is a prospective observational study based on an anonymous satisfaction questionnaire distributed to eligible adult patients after completion of the Day Hospital assessment. The primary objective is to assess overall patient satisfaction. Secondary objectives include evaluating satisfaction by specialty, identifying factors associated with satisfaction, and assessing the Net Promoter Score (NPS).

The results of this study are expected to help identify strengths and areas for improvement in multidisciplinary care, enhance patient-centered care, and support continuous quality improvement in oncology practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients (≥ 18 years old) * Patients undergoing a multidisciplinary "complex assessment" in a Day Hospital setting * Patients diagnosed with cancer and scheduled to receive injectable anticancer treatment * Ability to understand and complete the satisfaction questionnaire * Patients who have been informed and have not opposed participation Exclusion Criteria: * Patients under 18 years of age * Patients unable to complete the questionnaire (e.g., severe cognitive impairment or major language barrier) * Patients who refuse participation * Patients with incomplete Day Hospital complex assessment * Patients under legal protection (guardianship or curatorship) Patients under legal protection (guardianship or curatorship)

Primary outcome measure(s)

  • Overall Patient Satisfaction — At completion of the Day Hospital assessment (within 1 month after assessment)
    Proportion of patients reporting high overall satisfaction following the multidisciplinary complex assessment, measured using an anonymous satisfaction questionnaire.

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier de Martigues Martigues Bouches du Rhone Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07560423 on ClinicalTrials.gov ↗ ← All trials in France